Resequencing microarray technology for genotyping human papillomavirus in cervical smears.
There are more than 40 human papillomaviruses (HPVs) belonging to the alpha genus that cause sexually transmitted infections; these infections are among the most frequent and can lead to condylomas and anogenital intra-epithelial neoplasia. At least 18 of these viruses are causative agents of anogen...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4226468?pdf=render |
| _version_ | 1818144307145605120 |
|---|---|
| author | Nicolas Berthet Michael Falguières Claudia Filippone Chloé Bertolus Christine Bole-Feysot Sylvain Brisse Antoine Gessain Isabelle Heard Michel Favre |
| author_facet | Nicolas Berthet Michael Falguières Claudia Filippone Chloé Bertolus Christine Bole-Feysot Sylvain Brisse Antoine Gessain Isabelle Heard Michel Favre |
| author_sort | Nicolas Berthet |
| collection | DOAJ |
| description | There are more than 40 human papillomaviruses (HPVs) belonging to the alpha genus that cause sexually transmitted infections; these infections are among the most frequent and can lead to condylomas and anogenital intra-epithelial neoplasia. At least 18 of these viruses are causative agents of anogenital carcinomas. We evaluated the performance of a resequencing microarray for the detection and genotyping of alpha HPV of clinical significance using cloned HPV DNA. To reduce the number of HPV genotypes tiled on microarray, we used reconstructed ancestral sequences (RASs) as they are more closely related to the various genotypes than the current genotypes are among themselves. The performance of this approach was tested by genotyping with a set of 40 cervical smears already genotyped using the commercial PapilloCheck kit. The results of the two tests were concordant for 70% (28/40) of the samples and compatible for 30% (12/40). Our findings indicate that RASs were able to detect and identify one or several HPV in clinical samples. Associating RASs with homonym sequences improved the genotyping of HPV present in cases of multiple infection. In conclusion, we demonstrate the diagnostic potential of resequencing technology for genotyping of HPV, and illustrate its value both for epidemiological studies and for monitoring the distribution of HPV in the post-vaccination era. |
| first_indexed | 2024-12-11T11:45:29Z |
| format | Article |
| id | doaj.art-f740e14b7b6f4337a3a937c58cf59a50 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-11T11:45:29Z |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-f740e14b7b6f4337a3a937c58cf59a502022-12-22T01:08:30ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01911e10930110.1371/journal.pone.0109301Resequencing microarray technology for genotyping human papillomavirus in cervical smears.Nicolas BerthetMichael FalguièresClaudia FilipponeChloé BertolusChristine Bole-FeysotSylvain BrisseAntoine GessainIsabelle HeardMichel FavreThere are more than 40 human papillomaviruses (HPVs) belonging to the alpha genus that cause sexually transmitted infections; these infections are among the most frequent and can lead to condylomas and anogenital intra-epithelial neoplasia. At least 18 of these viruses are causative agents of anogenital carcinomas. We evaluated the performance of a resequencing microarray for the detection and genotyping of alpha HPV of clinical significance using cloned HPV DNA. To reduce the number of HPV genotypes tiled on microarray, we used reconstructed ancestral sequences (RASs) as they are more closely related to the various genotypes than the current genotypes are among themselves. The performance of this approach was tested by genotyping with a set of 40 cervical smears already genotyped using the commercial PapilloCheck kit. The results of the two tests were concordant for 70% (28/40) of the samples and compatible for 30% (12/40). Our findings indicate that RASs were able to detect and identify one or several HPV in clinical samples. Associating RASs with homonym sequences improved the genotyping of HPV present in cases of multiple infection. In conclusion, we demonstrate the diagnostic potential of resequencing technology for genotyping of HPV, and illustrate its value both for epidemiological studies and for monitoring the distribution of HPV in the post-vaccination era.http://europepmc.org/articles/PMC4226468?pdf=render |
| spellingShingle | Nicolas Berthet Michael Falguières Claudia Filippone Chloé Bertolus Christine Bole-Feysot Sylvain Brisse Antoine Gessain Isabelle Heard Michel Favre Resequencing microarray technology for genotyping human papillomavirus in cervical smears. PLoS ONE |
| title | Resequencing microarray technology for genotyping human papillomavirus in cervical smears. |
| title_full | Resequencing microarray technology for genotyping human papillomavirus in cervical smears. |
| title_fullStr | Resequencing microarray technology for genotyping human papillomavirus in cervical smears. |
| title_full_unstemmed | Resequencing microarray technology for genotyping human papillomavirus in cervical smears. |
| title_short | Resequencing microarray technology for genotyping human papillomavirus in cervical smears. |
| title_sort | resequencing microarray technology for genotyping human papillomavirus in cervical smears |
| url | http://europepmc.org/articles/PMC4226468?pdf=render |
| work_keys_str_mv | AT nicolasberthet resequencingmicroarraytechnologyforgenotypinghumanpapillomavirusincervicalsmears AT michaelfalguieres resequencingmicroarraytechnologyforgenotypinghumanpapillomavirusincervicalsmears AT claudiafilippone resequencingmicroarraytechnologyforgenotypinghumanpapillomavirusincervicalsmears AT chloebertolus resequencingmicroarraytechnologyforgenotypinghumanpapillomavirusincervicalsmears AT christinebolefeysot resequencingmicroarraytechnologyforgenotypinghumanpapillomavirusincervicalsmears AT sylvainbrisse resequencingmicroarraytechnologyforgenotypinghumanpapillomavirusincervicalsmears AT antoinegessain resequencingmicroarraytechnologyforgenotypinghumanpapillomavirusincervicalsmears AT isabelleheard resequencingmicroarraytechnologyforgenotypinghumanpapillomavirusincervicalsmears AT michelfavre resequencingmicroarraytechnologyforgenotypinghumanpapillomavirusincervicalsmears |